Prediction models for exacerbations in patients with COPD.

Area of Science:

• Pulmonary Medicine
• Medical Informatics
• Clinical Epidemiology

Background:

• Personalized medicine tailors treatments to individual patients.
• Risk stratification for adverse outcomes like exacerbations in chronic obstructive pulmonary disease (COPD) is crucial for personalized treatment strategies.
• Current prediction models for COPD exacerbations are not well-established, impacting the implementation of risk-stratified care.

Purpose of the Study:

• To identify and critically appraise existing prediction models for COPD exacerbations.
• To evaluate the quality and suitability of these models for risk-stratified treatment in COPD patients.

Main Methods:

• Systematic literature search to identify studies on COPD exacerbation prediction models.
• Critical appraisal of 27 prediction models from 25 included studies.
• Assessment of model heterogeneity, validation, individual risk estimation, and statistical quality.

Main Results:

• Significant heterogeneity was observed across the 27 prediction models in terms of predictors, statistical methods, and performance measures.
• Only two studies validated their developed models, and only one model provided individual exacerbation risk estimates.
• Few models employed high-quality statistical approaches for development and evaluation, with none meeting all requirements for risk-stratified treatment.

Conclusions:

• Existing prediction models for COPD exacerbations are insufficient for personalized, risk-stratified treatment.
• There is a need for harmonized approaches to develop and validate high-quality prediction models to advance personalized COPD care.